Nanodiscs as a modular platform for multimodal MR-optical imaging

Christiane E. Carney, Ivan L. Lenov, Catherine J. Baker, Keith W. Macrenaris, Amanda L. Eckermann, Stephen Sligar, Thomas J. Meade

Research output: Contribution to journalArticle

Abstract

Nanodiscs are monodisperse, self-assembled discoidal particles that consist of a lipid bilayer encircled by membrane scaffold proteins (MSP). Nanodiscs have been used to solubilize membrane proteins for structural and functional studies and deliver therapeutic phospholipids. Herein, we report on tetramethylrhodamine (TMR) tagged nanodiscs that solubilize lipophilic MR contrast agents for generation of multimodal nanoparticles for cellular imaging. We incorporate both multimeric and monomeric Gd(III)-based contrast agents into nanodiscs and show that particles containing the monomeric agent (ND2) label cells with high efficiency and generate significant image contrast at 7 T compared to nanodiscs containing the multimeric agent (ND1) and Prohance, a clinically approved contrast agent.

Original languageEnglish (US)
Pages (from-to)899-905
Number of pages7
JournalBioconjugate Chemistry
Volume26
Issue number5
DOIs
StatePublished - May 20 2015

Fingerprint

Optical Imaging
Contrast Media
Imaging techniques
Membrane Proteins
Lipid bilayers
Lipid Bilayers
Scaffolds
Nanoparticles
Labels
Phospholipids
Proteins
Membranes
Scaffolds (biology)
Therapeutics

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry

Cite this

Carney, C. E., Lenov, I. L., Baker, C. J., Macrenaris, K. W., Eckermann, A. L., Sligar, S., & Meade, T. J. (2015). Nanodiscs as a modular platform for multimodal MR-optical imaging. Bioconjugate Chemistry, 26(5), 899-905. https://doi.org/10.1021/acs.bioconjchem.5b00107

Nanodiscs as a modular platform for multimodal MR-optical imaging. / Carney, Christiane E.; Lenov, Ivan L.; Baker, Catherine J.; Macrenaris, Keith W.; Eckermann, Amanda L.; Sligar, Stephen; Meade, Thomas J.

In: Bioconjugate Chemistry, Vol. 26, No. 5, 20.05.2015, p. 899-905.

Research output: Contribution to journalArticle

Carney, CE, Lenov, IL, Baker, CJ, Macrenaris, KW, Eckermann, AL, Sligar, S & Meade, TJ 2015, 'Nanodiscs as a modular platform for multimodal MR-optical imaging', Bioconjugate Chemistry, vol. 26, no. 5, pp. 899-905. https://doi.org/10.1021/acs.bioconjchem.5b00107
Carney CE, Lenov IL, Baker CJ, Macrenaris KW, Eckermann AL, Sligar S et al. Nanodiscs as a modular platform for multimodal MR-optical imaging. Bioconjugate Chemistry. 2015 May 20;26(5):899-905. https://doi.org/10.1021/acs.bioconjchem.5b00107
Carney, Christiane E. ; Lenov, Ivan L. ; Baker, Catherine J. ; Macrenaris, Keith W. ; Eckermann, Amanda L. ; Sligar, Stephen ; Meade, Thomas J. / Nanodiscs as a modular platform for multimodal MR-optical imaging. In: Bioconjugate Chemistry. 2015 ; Vol. 26, No. 5. pp. 899-905.
@article{f905257aab8d40838a65d9a589826a0a,
title = "Nanodiscs as a modular platform for multimodal MR-optical imaging",
abstract = "Nanodiscs are monodisperse, self-assembled discoidal particles that consist of a lipid bilayer encircled by membrane scaffold proteins (MSP). Nanodiscs have been used to solubilize membrane proteins for structural and functional studies and deliver therapeutic phospholipids. Herein, we report on tetramethylrhodamine (TMR) tagged nanodiscs that solubilize lipophilic MR contrast agents for generation of multimodal nanoparticles for cellular imaging. We incorporate both multimeric and monomeric Gd(III)-based contrast agents into nanodiscs and show that particles containing the monomeric agent (ND2) label cells with high efficiency and generate significant image contrast at 7 T compared to nanodiscs containing the multimeric agent (ND1) and Prohance, a clinically approved contrast agent.",
author = "Carney, {Christiane E.} and Lenov, {Ivan L.} and Baker, {Catherine J.} and Macrenaris, {Keith W.} and Eckermann, {Amanda L.} and Stephen Sligar and Meade, {Thomas J.}",
year = "2015",
month = "5",
day = "20",
doi = "10.1021/acs.bioconjchem.5b00107",
language = "English (US)",
volume = "26",
pages = "899--905",
journal = "Bioconjugate Chemistry",
issn = "1043-1802",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - Nanodiscs as a modular platform for multimodal MR-optical imaging

AU - Carney, Christiane E.

AU - Lenov, Ivan L.

AU - Baker, Catherine J.

AU - Macrenaris, Keith W.

AU - Eckermann, Amanda L.

AU - Sligar, Stephen

AU - Meade, Thomas J.

PY - 2015/5/20

Y1 - 2015/5/20

N2 - Nanodiscs are monodisperse, self-assembled discoidal particles that consist of a lipid bilayer encircled by membrane scaffold proteins (MSP). Nanodiscs have been used to solubilize membrane proteins for structural and functional studies and deliver therapeutic phospholipids. Herein, we report on tetramethylrhodamine (TMR) tagged nanodiscs that solubilize lipophilic MR contrast agents for generation of multimodal nanoparticles for cellular imaging. We incorporate both multimeric and monomeric Gd(III)-based contrast agents into nanodiscs and show that particles containing the monomeric agent (ND2) label cells with high efficiency and generate significant image contrast at 7 T compared to nanodiscs containing the multimeric agent (ND1) and Prohance, a clinically approved contrast agent.

AB - Nanodiscs are monodisperse, self-assembled discoidal particles that consist of a lipid bilayer encircled by membrane scaffold proteins (MSP). Nanodiscs have been used to solubilize membrane proteins for structural and functional studies and deliver therapeutic phospholipids. Herein, we report on tetramethylrhodamine (TMR) tagged nanodiscs that solubilize lipophilic MR contrast agents for generation of multimodal nanoparticles for cellular imaging. We incorporate both multimeric and monomeric Gd(III)-based contrast agents into nanodiscs and show that particles containing the monomeric agent (ND2) label cells with high efficiency and generate significant image contrast at 7 T compared to nanodiscs containing the multimeric agent (ND1) and Prohance, a clinically approved contrast agent.

UR - http://www.scopus.com/inward/record.url?scp=84930211313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930211313&partnerID=8YFLogxK

U2 - 10.1021/acs.bioconjchem.5b00107

DO - 10.1021/acs.bioconjchem.5b00107

M3 - Article

C2 - 25830565

AN - SCOPUS:84930211313

VL - 26

SP - 899

EP - 905

JO - Bioconjugate Chemistry

JF - Bioconjugate Chemistry

SN - 1043-1802

IS - 5

ER -